- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Lifecare ASA: Invitation to presentation of Q1 2025 results and strategic update | 8 | Oslo Børs | ||
| 24.04. | Lifecare ASA: Minutes from Annual General Meeting | 1 | Oslo Børs | ||
| 23.04. | Lifecare ASA: Updated company presentation | 4 | Oslo Børs | ||
| 03.04. | Lifecare ASA: Annual General Meeting | - | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 28.03. | Lifecare ASA Annual Report 2024 | 1 | Oslo Børs | ||
| 25.03. | Lifecare ASA: LIFE: First positive indication of increased sensor sensitivity in ongoing longevity study | 3 | Oslo Børs | ||
| 20.03. | Lifecare ASA: Lifecare scientific updates: CGM symposium in Bergen, consensus recommendations from the Diabetes Technology Society and presentation of data at ATTD 2025 | 5 | Oslo Børs | ||
| 21.02. | Lifecare ASA: Deutlicher Umsatzrückgang und steigende Verluste im Jahresabschluss | 2 | IT BOLTWISE | ||
| 20.02. | LIFE: Lifecare ASA Q4 2024 | 4 | Oslo Børs | ||
| 14.02. | Lifecare ASA: Financial calendar | 3 | Oslo Børs | ||
| 04.02. | Lifecare ASA: LIFE: Improved chemistry successfully tested in sensor | 4 | Oslo Børs | ||
| 16.01. | Lifecare ASA: Financial calendar | 2 | Oslo Børs | ||
| 14.01. | Lifecare ASA: LIFE Fivefold improvement of sensor chemistry sensitivity | 6 | Oslo Børs | ||
| 21.10.24 | Nasdaq Stockholm AB: Admission to trading of Lifecare ASA on First North NOK | 267 | GlobeNewswire | Nasdaq Stockholm AB has admitted Lifecare ASA shares to trading on First North
NOK, with effect from October 22, 2024.
The shares will be traded on the First North NOK segment.
Short name: LIFEo... ► Artikel lesen | |
| 01.10.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 01.10.2024 | 781 | Xetra Newsboard | The following instruments on XETRA do have their first trading 01.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 01.10.2024
Aktien
1 CA09972D1069 Borealis Mining Co.... ► Artikel lesen | |
| 30.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.09.2024 | 415 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 30.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.09.2024ISIN Name
AU000000MCT4... ► Artikel lesen | |
| 30.09.24 | XFRA ISIN CHANGE | 798 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US10501E2019 Brainstorm Cell Therapeutics Inc. 30.09.2024 US10501E3009 Brainstorm Cell Therapeutics Inc. 01.10.2024 Tausch... ► Artikel lesen | |
| 20.05.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.05.2024 | 311 | Xetra Newsboard | Das Instrument 8OB SE0016844468 COMPODIUM INTL. AB EQUITY wird cum Kapitalmassnahme gehandelt am 20.05.2024 und ex Kapitalmassnahme am 21.05.2024 The instrument 8OB SE0016844468 COMPODIUM INTL. AB EQUITY... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 62,80 | -2,41 % | Roku Analyst Says TV's Future Hinges On This 'Powerful' Cost Saver, But It's Still Early | ||
| SERNOVA BIOTHERAPEUTICS | 0,129 | -5,15 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
| BOSTON SCIENTIFIC | 93,80 | +1,74 % | Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? | ||
| PAUL HARTMANN | 250,00 | -0,40 % | Dividendenbekanntmachungen (02.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,175 USD 0,155 EUR AKER ASA NO0010234552 26,5 NOK 2,2495 EUR ALIMAK GROUP AB SE0007158910 3 SEK 0... ► Artikel lesen | |
| SYSMEX | 15,300 | -3,16 % | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
| ADDLIFE | 17,020 | -0,53 % | Dividendenbekanntmachungen (09.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 5 SEK 0,4573 EUR ADDLIFE AB SE0014401378 0,75 SEK 0,0686 EUR ALLIANZ SE DE0008404005 - 15,4 EUR ALZCHEM GROUP... ► Artikel lesen | |
| EMBECTA | 10,400 | 0,00 % | Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results | PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.11.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 19.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.11.2024ISIN NameAU000000SVW5 SEVEN... ► Artikel lesen | |
| ENOVIS | 32,400 | -0,61 % | Enovis Corporation: Enovis Announces First Quarter 2025 Results | Continued commercial momentum with first-quarter sales growth of 8% on a reported basis and strong adjusted EBITDA margin expansion First-quarter Reconstructive sales grew 11% year-over-year on a reported... ► Artikel lesen | |
| KANGJI MEDICAL | 0,835 | +1,21 % | KANGJI MEDICAL (09997): TERMINATION OF DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF A SUBSIDIARY AND LAND RESUMPTION AGREEMENT WITH GOVERNMENT ... | ||
| PULMONX | 2,840 | -4,05 % | Pulmonx Corporation: Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results | REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| SI-BONE | 17,000 | +1,19 % | SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance | First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million, representing... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,595 | -3,25 % | PEIJIA-B (09996): GRANT OF SHARE OPTIONS | ||
| KOOTH | 1,600 | -0,62 % | Kooth PLC - Annual Financial Report |
Das Unternehmen LIFECARE ASA kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,002 (+0,31 %) liegt der Kurs bei 0,656 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.